Home
Inbox
Search
View Abstract
Content
Session(s)
MK-7264, a P2X3 Receptor Antagonist, Reduces Cough Frequency in Patients with Refractory Chronic Cough: Results from a Randomized, Controlled, Phase 2b Clinical Trial
Download
Send by Mail
View Handout
Home
Inbox
Search